CG
RCEL icon

Cutler Group’s Avita Medical RCEL Stock Holding History

Cutler Group’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$7K Hold
450
– – ﹤0.01% 1447
2023
Q4 		$6K Hold
450
– – ﹤0.01% 2673
2023
Q3 		$6K Sell
450
-430
-49% -$7.28K ﹤0.01% 2778
2023
Q2 		$14K Buy
880
+80
+10% +$1.17K ﹤0.01% 2059
2023
Q1 		$11K Buy
+800
New +$8.51K ﹤0.01% 2280
2022
Q4 		– Sell
-1,500
Closed -$7K – 5058
2022
Q3 		$7K Hold
1,500
– – ﹤0.01% 3406
2022
Q2 		$7K Hold
1,500
– – ﹤0.01% 3488
2022
Q1 		$12K Buy
1,500
+1,300
+650% +$12K ﹤0.01% 3483
2021
Q4 		$2K Sell
200
-200
-50% -$3.05K ﹤0.01% 4802
2021
Q3 		$7K Hold
400
– – ﹤0.01% 4237
2021
Q2 		$8K Hold
400
– – ﹤0.01% 4102
2021
Q1 		$7K Buy
+400
New +$9.3K ﹤0.01% 4138

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Cutler Group's RCEL Position: Q1 2024 in Review

Cutler Group held its Avita Medical (RCEL) position steady in Q1 2024 at 450 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1447.

Cutler Group first reported a position in RCEL in Q1 2021 and has held it in 12 quarters since. The position peaked at $14K in Q2 2023. 82 funds tracked by Wall St. Rank hold RCEL as of Q1 2024.

  • Cutler Group held 450 shares of Avita Medical worth $7K as of Q1 2024.
  • Cutler Group left its Avita Medical share count unchanged in Q1 2024.
  • Avita Medical made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1447 holding.
  • Cutler Group first reported a position in Avita Medical in Q1 2021 and has held it in 12 quarters since.
  • Cutler Group's Avita Medical position peaked at $14K in Q2 2023.
  • 82 funds tracked by Wall St. Rank held Avita Medical as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.